Search Results 1211-1220 of 15768 for Emesis

  1. A Study to Identify Outcome Measures in Eosinophilic Gastrointestinal Disorders - Mayo Clinic

    People with eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), and eosinophilic colitis (EC) normally undergo endoscopy and/or colonoscopy (scope down ...

  2. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  3. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  4. Chronic sinusitis - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  5. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  6. Anesthesiology and Perioperative Medicine - Doctors - Mayo Clinic

    Mayo Clinic's Department of Anesthesiology sees more than 145000 patients each year and integrates patient care, research and education, resulting in ...

  7. Esophagectomy - Doctors & Departments - Mayo Clinic

    The role of endoscopic methods in treating Barrett esophagus with high-grade dysplasia to avoid esophagectomy. Key research is now also focused on managing your ...

  8. Gastroenterology and Hepatology - Clinical trials

    One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...

  9. Patient Stories - Kristina F. DeMatas, D.O. - Mayo Clinic

    Kristina F. DeMatas, D.O. · Family Physician · Sports Medicine Specialist.

  10. A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) (SKYSCRAPER-14) - Mayo Clinic

    About this study. The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in ...